Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
NOVADEL PHARMA INC (NVDL) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/30/2012 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
03/21/2012 8-K Quarterly results
02/13/2012 4 Moorin Jay (10% Owner) has filed a Form 4 on NOVADEL PHARMA INC
02/13/2012 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/08/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Term Sheet, by and between the Company and Apricus Biosciences, Inc"
02/01/2012 8-K Form 8-K - Current report
01/31/2012 8-K/A Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
01/20/2012 8-K Form 8-K - Current report
01/19/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated Bylaws of NovaDel Pharma Inc",
"Amended and Restated Bylaws of NovaDel Pharma Inc. (redlined to show amended text)",
"Letter, from Mark Baric to NovaDel Pharma Inc",
"Letter, from Thomas Bonney to NovaDel Pharma Inc",
"Letter, from Charles Nemeroff, M.D. to NovaDel Pharma Inc",
"NovaDel Continuing to Explore Strategic Alternatives"
11/14/2011 8-K Form 8-K - Current report
11/01/2011 8-K Form 8-K - Current report
11/01/2011 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/01/2011 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
11/01/2011 10-Q Quarterly Report for the period ended September 30, 2011
08/31/2011 8-K Form 8-K - Current report
08/22/2011 8-K Form 8-K - Current report
08/12/2011 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "NovaDel Reports Financial Results for Second Quarter 2011"
08/12/2011 BW NovaDel Reports Financial Results for Second Quarter 2011
08/12/2011 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
08/12/2011 10-Q Quarterly Report for the period ended June 30, 2011
07/08/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment to the Employment Agreement, by and between the Company and David H. Bergstrom, Ph.D"
06/27/2011 4 Baric Mark J (Director) has filed a Form 4 on NOVADEL PHARMA INC
06/27/2011 4 Bonney Thomas E (Director) has filed a Form 4 on NOVADEL PHARMA INC
06/27/2011 4 Nemeroff Charles (Director) has filed a Form 4 on NOVADEL PHARMA INC
06/27/2011 8-K Form 8-K - Current report
06/24/2011 BW NovaDel Pharma Inc. to Present at 2011 BIO International Convention
06/09/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "NovaDel Announces Changes in Management"
06/08/2011 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
06/08/2011 EFFECT Form EFFECT - Notice of Effectiveness
06/02/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "NovaDel Reports Opening of Duromist™ original IND with FDA"
05/31/2011 POS AM Form POS AM - Post-Effective amendments for registration statement
05/31/2011 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Form of Consent Agreement by and among the Company and the investors set forth therein"
05/17/2011 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/16/2011 8-K Quarterly results
Docs: "NovaDel Reports Financial Results for First Quarter 2011"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy